University Hospital Maastricht

Maastricht 6229HX

0 studies enrolling now · 11 studies all time

What they study most

Apnea of Prematurity, Guillain-Barré Syndrome, Hypertension, Miller Fisher Syndrome, Obstructive Hypertrophic Cardiomyopathy (oHCM), Ovarian Cancer, Post-essential Thrombocythemia Myelofibrosis, Post-polycythemia Vera Myelofibrosis, Primary Knee Arthroplasty, Primary Myelofibrosis, Prostate Cancer, Pulmonary Hypertension

Studies at this site

• ATTUNE Revision System in the Revision Total Knee Arthroplasty Population — Running, not enrolling
• ATTUNE® Revision- Complex Primary in Total Knee Arthroplasty Population — Running, not enrolling
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• International Guillain-Barré Syndrome Outcome Study — Completed
• Pacritinib Versus Best Available Therapy to Treat Patients With Myelofibrosis and Thrombocytopenia — Stopped early
• Caffeine for Apnea of Prematurity (CAP) — Completed
• An Efficacy and Safety Study of MORAb-003 in Platinum-Resistant or Refractory Relapsed Ovarian Cancer — Stopped early
• Rheos® Pivotal Trial — Completed
• Assessment of SpondyloArthritis Society (ASAS) Classification and Diagnostic Criteria for Early Axial Spondyloarthritis (SpA) — Status unconfirmed
• Efficacy and Safety of Oral Bosentan in Pulmonary Arterial Hypertension Class II — Completed
• A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer — Completed